Kenneth R. Chapman

ORCID: 0000-0002-2498-9859
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Asthma and respiratory diseases
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Respiratory and Cough-Related Research
  • Inhalation and Respiratory Drug Delivery
  • Respiratory Support and Mechanisms
  • Protease and Inhibitor Mechanisms
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Allergic Rhinitis and Sensitization
  • Particle accelerators and beam dynamics
  • Pediatric health and respiratory diseases
  • Pulmonary Hypertension Research and Treatments
  • Pain Management and Treatment
  • Eosinophilic Esophagitis
  • Peptidase Inhibition and Analysis
  • Neuroscience of respiration and sleep
  • Air Quality and Health Impacts
  • Blood Coagulation and Thrombosis Mechanisms
  • Pharmacological Effects and Assays
  • Pharmaceutical studies and practices
  • Delphi Technique in Research
  • Emergency and Acute Care Studies
  • IL-33, ST2, and ILC Pathways
  • School Health and Nursing Education
  • Particle Accelerators and Free-Electron Lasers
  • Pleural and Pulmonary Diseases

University of Toronto
2016-2025

Toronto General Hospital
1997-2025

University Health Network
2015-2024

University of Vermont
2024

Toronto Western Hospital
2014-2023

Atomic Weapons Establishment
2023

Texas Christian University
2022

The Spine Institute
2022

Pain Management Institute
2022

Translational Research Institute
2021

Most guidelines recommend either a long-acting beta-agonist (LABA) plus an inhaled glucocorticoid or muscarinic antagonist (LAMA) as the first-choice treatment for patients with chronic obstructive pulmonary disease (COPD) who have high risk of exacerbations. The role LABA-LAMA regimen in these is unclear.We conducted 52-week, randomized, double-blind, double-dummy, noninferiority trial. Patients had COPD history at least one exacerbation during previous year were randomly assigned to...

10.1056/nejmoa1516385 article EN New England Journal of Medicine 2016-05-15

Background: Treatment of moderate or severe chronic obstructive pulmonary disease (COPD) with combinations inhaled corticosteroids, long-acting β-agonists, and anticholinergic bronchodilators is common but unstudied. Objective: To determine whether combining tiotropium salmeterol fluticasone–salmeterol improves clinical outcomes in adults to COPD compared alone. Design: Randomized, double-blind, placebo-controlled trial conducted from October 2003 January 2006. Setting: 27 academic community...

10.7326/0003-4819-146-8-200704170-00152 article EN Annals of Internal Medicine 2007-04-17

Exhaled nitric oxide (NO) may aid in monitoring pulmonary disease. The single-breath NO profile (subjects with nose clip) was described as a peak followed by plateau (NO(PLAT)). Published exhaled values vary greatly, possibly due to contamination nasal and differing respiratory maneuvers. We developed technique measure NO, without having the subject maintain positive expiratory pressure (ensuring vellum closure), we examined variation NO(PLAT) over range of flows (4.2 1,550 ml/s). rose...

10.1164/ajrccm.155.1.9001322 article EN American Journal of Respiratory and Critical Care Medicine 1997-01-01

Inhaled allergens, acting through IgE-dependent mechanisms, are important triggers of asthma symptoms and inducers airway hyperresponsiveness inflammation. The effect anti-IgE recombinant humanized monoclonal antibody-E25 (rhuMAb-E25) on the provocation concentration allergen causing a 15% fall in FEV1 (allergen PC15) during allergen-induced early asthmatic response (EAR) was assessed multicenter, randomized, double-blind, parallel group study. Ten 11 allergic subjects randomized to receive...

10.1164/ajrccm.155.6.9196083 article EN American Journal of Respiratory and Critical Care Medicine 1997-06-01

Telephone surveys describing suboptimal asthma control may be biased by low response rates. In order to obtain an unbiased assessment of and assess its impact in primary care, care physicians used a 1-page questionnaire 50 consecutive patients. Of the 10,428 patients assessed 354 physicians, 59% were uncontrolled, 19% well-controlled 23% totally controlled. Physicians overestimated control, regarding only 42% as uncontrolled. more likely report plans alter regimens uncontrolled than...

10.1183/09031936.00039707 article EN European Respiratory Journal 2007-10-24

There is limited data on the risk factors and phenotypical characteristics associated with spirometrically confirmed COPD in never-smokers general population.To compare by gender severity of airway obstruction ever-smokers.We analysed from 5176 adults aged 40 years older who participated initial cross-sectional phase population-based, prospective, multisite Canadian Cohort Obstructive Lung Disease study. Never-smokers were defined as those a lifetime exposure <1/20 pack year. Logistic...

10.1136/thoraxjnl-2015-206938 article EN Thorax 2015-06-05

There are no studies on withdrawal of inhaled corticosteroids in patients long-term triple therapy the absence frequent exacerbations.To evaluate efficacy and safety direct de-escalation from to indacaterol/glycopyrronium nonfrequently exacerbating with chronic obstructive pulmonary disease (COPD).This 26-week, randomized, double-blind, triple-dummy study assessed change (110/50 μg once daily) or continuation (tiotropium [18 μg] daily plus combination salmeterol/fluticasone propionate...

10.1164/rccm.201803-0405oc article EN American Journal of Respiratory and Critical Care Medicine 2018-05-20

Rationale: Studies of excised lungs show that significant airway attrition in the “quiet” zone occurs early chronic obstructive pulmonary disease (COPD).Objectives: To determine if total number airways quantified vivo using computed tomography (CT) reflects airway-related changes and is associated with lung function decline independent emphysema COPD.Methods: Participants multicenter, population-based, longitudinal CanCOLD (Canadian Chronic Obstructive Lung Disease) study underwent...

10.1164/rccm.201704-0692oc article EN American Journal of Respiratory and Critical Care Medicine 2017-09-08
Tim Harrison Pascal Chanez Francesco Menzella Giorgio Walter Canonica Renaud Louis and 95 more Borja G. Cosío Njira Lugogo Arjun Mohan Annie Burden Lawrence McDermott Esther Garcia Gil James Zangrilli Wolfgang Pohl Robert Voves Maud Deschampheleire Renaud Louis Jean‐Benoît Martinot Rudi Peché Kenneth R. Chapman Amarjit Cheema Delbert R. Dorscheid J. Mark FitzGerald Rémi Gagnon William Patrick Killorn Ronald Olivenstein George Philteos Clare D. Ramsey Julia Rolf Brandie Walker Ole Hilberg Tina Skjold Ingrid Louise Titlestad Auli Hakulinen Maritta Kilpeläinen M. Ben Hayoun Philippe Bonniaud Arnaud Bourdin Pascal Chanez Frédéric de Blay Gaëtan Deslée Gilles Devouassoux A. Didier Y. Douadi Stéphanie Fry Gilles Garcia Pierre‐Olivier Girodet Christophe Leroyer A. Magnan Guillaume Mahay C. Nocent Christophe Pison Pauline-Marie Roux Camille Taillé Juliana-Angelica Tiotiu Ekkehard Beck Margret Jandl Christian Kaehler F Käßner Frank Koesters Juliane Kronsbein Thomas Schaum Christian Schulz Dirk Skowasch Christian Taube Tobias Welte A de Roux Bianca Beghè Francesco Blasi Giorgio Walter Canonica Giovanna Elisiana Carpagnano Cristiano Caruso Angelo Guido Corsico Elio Constantino Nunzio Crimi Piero Maestrelli Francesco Menzella Manlio Milanese Alberto Papi Girolamo Pelaia Laura Pini Pierachille Santus Eleonora Savi Nicola Scichilone Gianenrico Senna Giuseppe Spadaro Adriano Vaghi Steven Gans Jurgen Hölters Bas Langeveld Willem R. Pieters Gerald Staaks Ilonka van Veen Jan Willem van den Berg Gunnar Einvik Sverre Lehmann Ismael Ali García Carlos Almonacid Irina Bobolea Paloma Campo Mozo Gustavo de Luiz

10.1016/s2213-2600(20)30414-8 article EN The Lancet Respiratory Medicine 2020-12-22
John W. Upham Chantal Le Lievre David J. Jackson Matthew Masoli Michael E. Wechsler and 95 more David Price Adel Mansur Aikaterini Detoraki Alan Altraja Alan L. James Alexandra Nanzer-Kelly Andréanne Côté Andrew Menzies‐Gow Andriana Ι. Papaioannou Anne-Maree Cheffins Arnaud Bourdin Bassam Mahboub Brian J. Lipworth C.A. Celis-Preciado Carlos A. Torres‐Duque Caterina Bucca Celeste Porsbjerg Charlotte Suppli Ulrik Christopher J. Corrigan Christian Taube Claude S. Farah Constance H. Katelaris David Langton Dermot Ryan Désirée Larenas‐Linnemann Εleftherios Ζervas Enrico Heffler Flavia Hoyte Francesca Puggioni George Christoff Giorgio Walter Canonica Giovanna Elisiana Carpagnano Giuseppe Guida Gregory Katsoulotos Guy Brusselle Hitashi Rupani Hubertus Jersmann I. Clifton Jaideep Dhariwal James Fingleton Jane Duke Janet Rimmer John Aubrey Douglass João Fonseca Job F. M. van Boven John Corless John Harrington Jorge Máspero José Luís San Miguel Kanok Pipatvech Karrinda Kenny Kenneth R. Chapman Κonstantinos Κostikas Lauri Lehtimäki Li Ping Chung Liam G. Heaney Liang‐Wen Hang Louis‐Philippe Boulet Luis Pérez de Llano L Ricciardi Majdy Idrees Manlio Milanese Maria Elisabetta Conte Maria Teresa Costantino Mariko Koh Siyue Mark Fitzgerald Mark Hew Matthew Peters Ming‐Ju Tsai Mitesh Patel Mohammad Hashim Khan Mohsen Sadatsafavi Mona Al‐Ahmad Mona‐Rita Yacoub Mónica De Gennaro Naghmeh Radhakrishna Nicola A. Hanania Nikolaos G. Papadopoulos Njira Lugogo Norma Linaker Nunzio Crimi Paddy Dennison Parameswaran Nair Patrick Mitchell Paul M. O’Byrne Paul Pfeffer Paula Kauppi Pauline Hughes Peter G. Middleton Peter Wark Philip Bardin Pin‐Kuei Fu Praveen Akuthota Rekha Chaudhuri R. Diaz Campos

10.1016/j.jaip.2021.06.041 article EN The Journal of Allergy and Clinical Immunology In Practice 2021-07-13

BACKGROUND: Two Canadian studies showed that 55% of patients with asthma had daily symptoms (in 1996) and 57% suffered from poorly controlled 1999). OBJECTIVES: To assess the state control adult Canadians, knowledge practices physicians actively involved in care asthma. METHODS: Telephone interviews were conducted adults 18 to 54 years age who been diagnosed at least six months before survey, did not have chronic obstructive pulmonary disease a smoking history fewer than 20 pack‐years....

10.1155/2006/753083 article EN cc-by Canadian Respiratory Journal 2006-01-01

Chronic exposure to traffic-related air pollution (TRAP) may contribute premature mortality, but few studies date have addressed this topic.In study we assessed the association between TRAP and mortality in Toronto, Ontario, Canada.We collected nitrogen dioxide samples over two seasons using duplicate two-sided Ogawa passive diffusion samplers at 143 locations across Toronto. We calibrated land use regressions predict NO2 on a fine scale within used interpolations levels of particulate...

10.1289/ehp.11533 article EN Environmental Health Perspectives 2009-01-05

BACKGROUND: Several sets of Canadian guidelines for the diagnosis and management asthma have been published over past 15 years. Since last revision 1999 Asthma Consensus Report, important new studies highlighted need to incorporate information into guidelines. OBJECTIVES: To review literature on adult between January 2000 June 2003; evaluate influence evidence recommendations made in Guidelines its 2001 update; report management. METHODS: Three specific topics which affected previous were...

10.1155/2004/271362 article EN cc-by Canadian Respiratory Journal 2004-01-01

Relapse after the treatment of acute asthma in emergency room is common (occurring 25 to 30 percent cases) and not accurately predicted by any available measurements. We studied usefulness prednisone reducing this high rate relapse.One hundred twenty-two patients treated for exacerbations were assigned a randomized, double-blind fashion receive at discharge either eight days (the dose being tapered from 40 0 mg per day) or matching placebo. Ninety-three subsequently discharged participated...

10.1056/nejm199103213241202 article EN New England Journal of Medicine 1991-03-21
Coming Soon ...